NEUROLOGISK KLINIK ApS: Financial statements 2021
CVR: 31748429
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
NEUROLOGISK KLINIK ApS (CVR 31748429) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 258,821 and a net result of DKK 699,794 compared with DKK 194,614 the year before. That is an increase of 61.2% compared with the year before. Equity in the 2021 report amounted to DKK 1,450,180. The solvency ratio was 75.6%.
- Gross Profit
- DKK 258,821
- Profit/Loss
- DKK 699,794
- Equity
- DKK 1,450,180
- Total Assets
- DKK 1,918,642
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 259K | 700K | 1.5M | - |
| 2020 | - | 161K | 195K | 863K | - |
| 2019 | - | 259K | 145K | 521K | - |
| 2018 | - | 89K | 13K | 376K | 0 |
| 2017 | - | 202K | 100K | 363K | 0 |
Official annual report
Find more companies like NEUROLOGISK KLINIK ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
NEUROLOGISK KLINIK ApS has published its annual report for 2020. Gross profit came to DKK 160,599, and the net result was DKK 194,614.
About NEUROLOGISK KLINIK ApS
NEUROLOGISK KLINIK ApS was a Danish company of the type Anpartsselskab based in Langå, founded in 2008. The company has been dissolved on 19 December 2023. The company was registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SOMNOLEPSION BIOTECH ApS. The company has 0 employees (2020). In 2022, the company reported a gross profit of DKK 99,955 and a net result of DKK 265,911 compared with DKK 699,794 the year before. Equity in the 2022 report amounted to DKK 1,716,091.
